TORONTO, ONTARIO–(Marketwired – May 18, 2016) –
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
Nurcapital Corporation Ltd. (“Nurcapital“) (TSX VENTURE:NCL.P) announces that it has completed a non-brokered private placement financing pursuant to which it raised gross proceeds of $97,200 through the issuance of 486,000 common shares in the capital of Nurcapital at a price of $0.20 per share. All securities issued pursuant to the financing are subject to a four-month hold period.
No finders’ fees were paid, no insiders subscribed for shares and no new insiders were created. The net proceeds will be used by Nurcapital for identification of a “qualifying transaction” and for working capital pursuant to the rules of the TSX Venture Exchange (the “Exchange“) governing “capital pool companies”.
Including the issuance of shares detailed in this news release, there are currently 3,744,500 common shares issued and outstanding.
About Nurcapital Corporation Ltd.
Nurcapital is a capital pool company within the meaning of the policies of the Exchange. Nurcapital does not have any operations and has no assets other than cash. Nurcapital’s business is to identify and evaluate businesses and assets with a view to completing a “qualifying transaction” under the policies of the Exchange.
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Although Nurcapital believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, Nurcapital disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release does not constitute and the subject matter hereof is not, an offer for sale or a solicitation of an offer to buy, in the United States or to any “U.S Person” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “1933 Act”)) of any equity or other securities of Nurcapital. The securities of Nurcapital have not been registered under the 1933 Act and may not be offered or sold in the United States (or to a U.S. Person) absent registration under the 1933 Act or an applicable exemption from the registration requirements of the 1933 Act.
